| Literature DB >> 30223029 |
Shwe Phyu Hlaing1, Jihyun Kim2, Juho Lee1, Nurhasni Hasan1, Jiafu Cao1, Muhammad Naeem1, Eun Hee Lee3, Jae Ho Shin4, Yunjin Jung1, Bok-Leul Lee1, Byung Hak Jhun5, Jin-Wook Yoo6.
Abstract
Methicillin-resistant Staphylococcus aureus (MRSA)-infected wounds have become a significant clinical issue worldwide. Recently, nitric oxide (NO) has emerged as a potent antibacterial agent against MRSA infections and a wound-healing enhancer. Nevertheless, clinical applications of NO have been largely restricted by its gaseous state and short half-life. In this study, our aim was to develop S-nitrosoglutathione (GSNO, an endogenous NO donor)-loaded poly(lactic-co-glycolic acid) [PLGA] microparticles (GSNO-MPs) that release NO over a prolonged period, to accelerate the healing of MRSA-infected wounds with less frequent dosing. GSNO was successfully encapsulated into PLGA microparticles by a solid-in-oil-in-water emulsion solvent evaporation method. Scanning electron microscopy and X-ray diffraction analyses confirmed the successful fabrication of GSNO-MPs. The latter released NO in a prolonged manner over 7 days and exerted a remarkable antibacterial activity against MRSA in a concentration- and time-dependent manner. Moreover, GSNO-MPs had good antibacterial efficacy and were found to accelerate wound healing in a mouse model of MRSA-infected wounds. Therefore, NO-releasing MPs devised in this study may be a promising option for the treatment of cutaneous wounds infected by drug-resistant bacteria such as MRSA.Entities:
Keywords: Methicillin-resistant Staphylococcus aureus; Nitric oxide; Poly (lactic-co-glycolic acid) microparticles; S-nitrosoglutathione; Wound healing
Mesh:
Substances:
Year: 2018 PMID: 30223029 DOI: 10.1016/j.ejpb.2018.09.009
Source DB: PubMed Journal: Eur J Pharm Biopharm ISSN: 0939-6411 Impact factor: 5.571